Yahoo
NYSE - BOATS Real Time Price USD

Alcon Inc. (ALC)

73.63 +2.18 (+3.05%)
At close: November 2 at 4:00:02 PM EST
73.80 +0.17 (+0.23%)
Overnight: 3:10:52 AM EST
Trade Alcon on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. David J. Endicott
CEO & Director 4.07M -- 1965
Mr. Timothy C. Stonesifer
Senior VP & CFO -- -- 1967
Mr. Ian Bell
Senior VP & COO -- -- 1971
Margaret Buckley
Chief Accounting Officer -- -- --
Dr. Franck Leveiller Ph.D.
SVP of Global Research & Development and Chief Scientific Officer -- -- --
Mr. Muru Murugappan
Senior VP and Chief Information & Transformation Officer -- -- --
Mr. Daniel Cravens
Vice President of Investor Relations -- -- --
Mr. Royce R. Bedward J.D.
Senior VP, General Counsel & Corporate Secretary -- -- 1966
Ms. Kimberly Martin
Senior VP and Chief HR & Corporate Communications -- -- 1975
Mr. Leon Sergio Duplan Fraustro
Senior VP & President of Americas -- -- 1968

Alcon Inc.

Chemin de Blandonnet 8
Vernier
Geneva, 1214
Switzerland
41 589 112 110 https://www.alcon.com
Sector: 
Healthcare
Full Time Employees: 
25,000

Description

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Corporate Governance

Alcon Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 10, 2026 at 9:00 PM UTC

Alcon Inc. Earnings Date

Recent Events

August 10, 2026 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

May 15, 2026 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 7, 2026 at 12:00 AM UTC

Dividend Date

May 6, 2026 at 12:00 AM UTC

Ex-Dividend Date

May 5, 2026 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

April 2, 2026 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

February 24, 2026 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

January 7, 2026 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

December 9, 2025 at 12:00 AM UTC

DFAN14A: Proxy Statements

November 12, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: